Skip to content
10-Q

Quarterly Report

SYLVAMO CORPORATION SLVM

0001856485-26-000019

← back to feed
Filed
May 8, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 39.74M sh
Shares Diluted Q1 2026 · Mar 31, 2026 39.6M sh
Shares Diluted Q1 2026 · Mar 31, 2025 41.5M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $0
Stock Repurchased Q1 2026 · Mar 31, 2025 $20M
Dividends Paid Q1 2026 · Mar 31, 2026 $18M
Dividends Paid Q1 2026 · Mar 31, 2025 $18M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$10M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $23M
Short Term Debt Q1 2026 · Mar 31, 2026 $23M
Short Term Debt Q1 2026 · Dec 31, 2025 $23M
Short Term Investments Q1 2026 · Mar 31, 2026 $76M
Short Term Investments Q1 2026 · Dec 31, 2025 $63M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $130M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $135M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $154M
Cash And Equivalents Q1 2026 · Dec 31, 2024 $205M
Stockholders Equity Q1 2026 · Mar 31, 2026 $979M
Stockholders Equity Q1 2026 · Dec 31, 2025 $966M
Stockholders Equity Q1 2026 · Mar 31, 2025 $908M
Stockholders Equity Q1 2026 · Dec 31, 2024 $847M
Current Liabilities Q1 2026 · Mar 31, 2026 $758M
Current Liabilities Q1 2026 · Dec 31, 2025 $716M
Current Assets Q1 2026 · Mar 31, 2026 $1.1B
Current Assets Q1 2026 · Dec 31, 2025 $1.08B
Total Assets Q1 2026 · Mar 31, 2026 $2.83B
Total Assets Q1 2026 · Dec 31, 2025 $2.76B
Total Assets restated Q1 2026 · Mar 31, 2025 $2.76B
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.08
Eps Diluted Q1 2026 · Mar 31, 2025 $0.65
Eps Basic Q1 2026 · Mar 31, 2026 −$0.08
Eps Basic Q1 2026 · Mar 31, 2025 $0.66
Sga Expense Q1 2026 · Mar 31, 2026 $73M
Sga Expense Q1 2026 · Mar 31, 2025 $73M
Net Income Q1 2026 · Mar 31, 2026 −$3M
Net Income Q1 2026 · Mar 31, 2025 $27M
Operating Income Q1 2026 · Mar 31, 2026 −$15M
Operating Income Q1 2026 · Mar 31, 2025 $44M
Revenue Q1 2026 · Mar 31, 2026 $755M
Revenue Q1 2026 · Mar 31, 2025 $821M